NFATC4 and cardiac hypertrophy: However, it is possible that cardiac piRNA expression has downstream effects on cellular signaling pathways that involve GSK3β, which is a known repressor of cardiac hypertrophy by phosphorylating proteins involved in cell proliferation such as β-catenin and NFATC4 [128].